SureTrader SureTrader
Home > Boards > Canadian > Medical - Healthcare >

Covalon Technology Limited (TSXV:COV)

TSXV:COV RSS Feed
Add TSXV:COV Price Alert      Hide Sticky   Hide Intro
Moderator:
Search This Board:
Last Post: 9/13/2016 12:36:58 PM - Followers: 19 - Board type: Free - Posts Today: 0

  

Covalon Technologies Ltd. researches, develops and commercializes new healthcare technologies that help save lives around the world. Covalon's patented technologies, products and services address the advanced healthcare needs of medical device companies, healthcare providers and individual consumers. Covalon's technologies are used to prevent, detect and manage medical conditions in specialty areas such as wound care, tissue repair, infection control, disease management, medical device coatings and biocompatibility.

http://www.covalon.com/
 

Trailing Financial Performance
Fiscal Quarter Products (Wound Care Sales) Medical Coating Systems (Specialized Medical 
Device Coatings)
Services Licensing & Royalty Fees    Total Revenue Earnings
             
Q3/2016 $2,549,328 $7,576 - $43,098 $2,600,002 ($156,792)
Q2/2016 $469,600 $10,826 $43,299 $274,023 $797,748 ($1,065,517)
Q1/2016 $1,943,231 - $72,000 $425,402 $2,440,633 $267,310
Q4/2015* $1,721,923 $262,500 $40,800 $72,198 $2,097,421 ($847,033)
Q3/2015 $1,741,133 $164,215 - $68,989 $1,974,337 ($129,272)
Q2/2015 $1,742,672 $312,519 - $125,085 $2,180,276 $264,340
Q1/2015 $767,091 $454,607 - $114,987 $1,336,685 ($229,820)
Q4/2014 $1,099,855 - - $106,304 $1,206,159 ($909,705)
Q3/2014 $1,119,559 $14,100 - $157,719 $1,291,378 ($240,156)
Q2/2014 $1,400,065 $462,000 - $179,526 $2,041,591 $431,211
Q1/2014 $733,590 - - $3,788,611 $4,522,201 $3,120,419
Q4/2013 $1,352,855 $71,092 - $130,706 $1,543,019 $125,319
Q3/2013 $1,411,220 - - $66,412 $1,477,632 $234,826
Q2/2013 $478,371 - - $51,482 $535,224 ($558,831)
Q1/2013 $520,523 - - $51,482 $572,005 ($794,481)
* - The company recategorized their revenues during their 2015 Annual Report review, old category names are written in parentheses in the column headings.  Changes include the addition of a new "Services" category of revenues.  Also, the new "Medical Device Coating Systems" category now longer includes the sales of the company's "SilverCoat Foley Catheter", which are now included in the "Products" category.

 

 


Licensed Products 

Smith&Nephew, BIOSTEP Collagen Matrix Dressing:
BIOSTEP webpage:  http://www.smith-nephew.com/professional/products/advanced-wound-management/biostep/

Medline, Silvertouch 100% Silicone Foley Catheters:
Silvertouch Foley Catheters webpage:  http://www.medline.com/product/Silvertouch-100-Silicone-Foley-Catheters/Z05-PF02119

 


 

Products marketed by Covalon

ColActive Plus - Collagen Matrix Dressing:  http://www.covalon.com/colactive-plus-advanced-wound-care

ColActive Transfer - Wound Contact Layer:  http://www.covalon.com/colactive-plus-advanced-wound-care

IV Clear - Wound Contact Layer:  
http://www.covalon.com/ivclear-antimicrobial-clear-silicone-adhesive-iv-dressing

SurgiClear - Wound Contact Layer:  http://www.covalon.com/surgiclear-antimicrobial-clear-silicone-adhesive-surgical-dressing

Silvercoat - Antimicrobial Silicone Foley Catheter:  http://www.covalon.com/silvercoat

 
 

 

  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
TSXV:COV
Current Price
Volume:
Bid Ask Day's Range
SureTrader
COV News: Covalon to Exhibit at the World Union of Wound Healing Societies in Florence, Italy 09/26/2016 08:00:00 AM
PostSubject
#213   Solid news. Sales outside the Saudi contracts TheMonolith 09/13/16 12:36:58 PM
#212   Expanding markets: Covalon Establishes Key Distribution Channel in Mexico zenvesting 09/13/16 08:40:02 AM
#211   Looks like more to come from the area TheMonolith 08/09/16 04:20:26 PM
#210   Covalon Wins Another $3.5 Million Twelve Month Contract zenvesting 08/09/16 08:16:40 AM
#209   Ahhhhh freak out! This ones a monsta, TheMonolith 08/05/16 11:44:44 AM
#208   Game changing news http://finance.yahoo.com/news/covalon-wins-7-6-million-12000 TheMonolith 08/03/16 04:31:35 PM
#207   Just read the news of the past year. TheMonolith 07/27/16 11:16:16 PM
#206   This chart is exquisite TheMonolith 07/25/16 06:28:33 PM
#205   Covalon's products are nicely presented on the Medline zenvesting 06/25/16 11:47:22 AM
#204   Great post from TheRock07 on another board: solarity 06/18/16 09:12:32 PM
#203   If you are wondering what happened today--------now you lolabean 06/15/16 03:58:05 PM
#202   Unfortunately, I also need to make another post zenvesting 05/31/16 10:56:04 AM
#201   The company said that the bad quarter was zenvesting 05/31/16 10:55:52 AM
#200   Thanks as we look forward to your update lolabean 05/31/16 12:47:15 AM
#199   Don't forget to tune in to the conference zenvesting 05/30/16 11:56:44 PM
#198   This was a very ugly quarterly report, the zenvesting 05/30/16 11:54:24 PM
#197   This should definitely be one to watch over zenvesting 03/15/16 02:18:56 PM
#196   Covalon will be at SAWC April 14th-17th: zenvesting 03/15/16 12:49:06 PM
#195   Covalon will be presenting at EWMA in May zenvesting 03/15/16 12:39:21 PM
#194   Covalon First Quarter, 2016 Earnings CC Recording Available - zenvesting 03/15/16 12:28:22 PM
#193   DrugandDeviceDigest.com coverage highlights "Greater bacterial kill than two zenvesting 12/12/15 09:56:16 AM
#192   A look at the market potential for Covalon's zenvesting 12/01/15 10:51:36 AM
#191   Doesn't take much imagination to identify the sales zenvesting 11/30/15 11:39:31 AM
#190   Good news today, catheter associated urinary tract infections zenvesting 11/30/15 10:36:48 AM
#189   Ok great thx. Gonna hang on for a while. Traderfan 08/29/15 12:11:57 PM
#188   Yes, they increased their SG&A costs quite a zenvesting 08/29/15 11:46:06 AM
#187   I see. I was surprised that they didn't Traderfan 08/29/15 07:25:55 AM
#186   It's not necessarily bad either, at least Covalon zenvesting 08/29/15 07:16:05 AM
#185   That doesn't sound too good, does it? Traderfan 08/29/15 05:39:04 AM
#184   From the MD&A: Molnlycke informed Covalon that Molnlycke zenvesting 08/29/15 12:41:20 AM
#183   Covalon Announces Strong Third Quarter Results zenvesting 08/29/15 12:39:29 AM
#182   zenvesting 05/01/15 07:26:32 AM
#181   Covalon will begin to market their own Antimicrobial zenvesting 02/28/15 10:45:02 AM
#180   Molnlycke presented Mepitel Film AM in 3 of zenvesting 02/28/15 09:28:27 AM
#179   ColActive now featured on the homepage of this zenvesting 02/28/15 09:16:07 AM
#178   Covalon Announces First Quarter Financial Results zenvesting 02/28/15 08:53:18 AM
#177   Clinical Performance of a New Clear Silicone Adhesive zenvesting 11/27/14 01:12:34 AM
#176   Hey Frank, zenvesting 11/25/14 11:37:30 AM
#175   Covalon to Present at Wounds UK Annual Conference zenvesting 11/10/14 05:17:14 PM
#174   Found some proof Molnlycke is investing in sales zenvesting 10/16/14 12:13:19 AM
#173   Interestingly enough, Covalon updated it's website to include zenvesting 09/10/14 10:21:52 AM
#172   JojoK, I think we need to take Brian zenvesting 09/07/14 12:17:02 AM
#171   I think some of the comparisons and misunderstanding lolabean 09/05/14 01:51:02 PM
#170   hey Zen, what's your thesis on COV? Could JojoK 09/05/14 01:28:55 PM
#169   Covalon presenting at Medical Fair Asia next week zenvesting 09/02/14 05:36:26 PM
#168   Covalon updated the Medical Device Coating Platform section zenvesting 09/02/14 05:33:41 PM
#167   You are totally correct regarding the relationship with lolabean 08/30/14 01:21:31 PM
#166   Covalon has a License and DISTRIBUTION agreement with zenvesting 08/30/14 12:41:34 PM
#165   Keep in mind that COV is transitioning to lolabean 08/28/14 01:45:40 PM
#164   COV I totally agree with you that this quarter lolabean 08/27/14 01:27:33 PM
PostSubject